




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
IF=2.2181.IntroductionMerozoitesurfaceprotein-1ofmalariaparasites,presentonthesurfaceofmerozoiteandplayingakeyroleintheinvasionprocess,isoneoftheleadingvaccinetargetsforbothP.falciparumandP.vivaxmalaria.MSP-1occursasa200kDaprecursorandundergoesstep-wiseproteolyticprocessingresultinginaglycosyl-phosphatidylinositol-anchored42kDaproteinfragment(MSP-142)onthesurfaceoffreemerozoite.AlargenumberofstudieshaveshowntheprotectivepotentialofMSP-1fragments(42and19kDa)ofP.falci-parumandP.yoelii.DNAvaccineshaveemergedasapromisingapproachforavarietyofinfectiousagentsincludingmalariaparasites.DNAbasedvaccinesareparticularlyimportantfordevelopingmultistage/multiantigenvaccinesforcomplexparasiteslikemalariatherebyinducingspecificandprotectiveimmunityagainstdifferentlifecyclestages(pre-erythrocytic,erythrocyticandsexualstages)ofmalaria.TheadvantagesofDNAvaccinesaretheeaseoftheirproductionandtheirabilitytoinduceresponseswithoutanyexogenousadjuvant,whichisanabsoluterequirementforproteinbasedvaccineformulations.DNAvaccineshavebeenshowntoinducestronghumoralandcellularresponsestomalarialantigensinimmunized.However,clinicaltrialsofthesecandidatevaccineswhenusedaloneorinrepeatedhomologousboostingregimenshavebeendisappointing,withshortlivedlowlevelsofinducedspecificT-cellsresponses.Sequentialimmunizationwithdifferentplasmids/vectorsknownasheterologousprime-boostingappearstobeabetterapproachandhasbeenshowntoinduceenhancedandpersistentlevelsofantibodyandcellmediatedimmuneresponsesagainstmalaria.Inheterologousprime-boostingstrategytheprimingwasdonewithDNAfollowedbytheboosterimmunizationwitharecombinantprotein,arecombinantviralvaccine,orexposuretotheliveorganism.InthepresentstudywehaveevaluatedtheimmunogenicityofaDNAvaccineencodingMSP-142ofP.vivaxusingprime-boostingstrategyinBALB/cmice.WehavealsocomparedtheimmunogenicityofPvMSP-142recombinantproteininBALB/cmice.2.MaterialsandmethodsDNAvaccineconstructsencodingP.vivaxMSP-142InvitrotransfectionofmammaliancellswithP.vivaxMSP-142–pcDNA3.1plasmidMonoclonalantibodiesagainstP.vivaxMSP-142LocalizationofP.vivaxMSP-142byindirectimmunofluorescenceSDS–PAGEandimmunoblottingPurificationofrecombinantP.vivaxMSP-142expressedinE.coliPurificationofplasmidforimmunizationImmunizationstudiesinmiceEnzymelinkedimmunosorbentassayDeterminationofIgGsubclassesCellproliferationassayDetectionofcytokinesIFN-γ,IL-2andIL-12byELISA3.Results
3.1.ConstructionofaP.vivaxmerozoitesurfaceprotein-142-pcDNA3.1plasmidDNAvaccineanditsinvitroexpressioninCOS1cells3.2.AntibodyresponsesinimmunemiceagainstP.vivaxmerozoitesurfaceprotein-142-pcDNA3.1DNAvaccineconstructandrecombinantPvMSP-142protein3.3.MeasurementofP.vivaxmerozoitesurfaceprotein-142specificIgGisotypesinimmunemicesera3.4.InvitroTcellresponsesagainstP.vivaxmerozoitesurfaceprotein-1423.5.InvitrocytokinesproductionagainstP.vivaxmerozoitesurfaceprotein-1424.DiscussionsInthepresentstudy,wehavepreparedaplasmidDNAconstructencodingP.vivaxPvMSP-142antigen.TheexpressionofPvMSP-142proteinwascheckedbyinvitrotransfectionofCOS-1mammaliancellswithPvMSP-142-pcDNA3.1plasmidDNAconstruct.ImmunogenicityofPvMSP-142DNAvaccineconstructwasinvestigatedbyprimingtheBALB/cmiceeitherwithPvMSP-142plasmidDNAorwithrecombinantPvMSP-142proteinandboostingwithrecombinantPvMSP-142protein.InthepresentstudywehaveconductedDNAvaccinationforP.vivaxMSP-142andcomparedtheimmunogenicityofDNAvaccineconstructwithcorrespondingproteinvaccinationinBALB/cmice.ImmunizationofmicewithrecombinantPvMSP-142resultedintheinductionofhightitresofanti-rPvMSP-142antibodiesthanthatofDNAimmunization.However,theantibodytitresobservedinPvMSP-142plasmidDNAimmunizedmiceweresignificantlyhigherthanthemiceinthecontrolgroup(vectorimmunized).DNAvaccineplasmidsencodingmerozoitesurfaceprotein-1frommurinemalariahasbeenshowntoprovideprotectionagainstmalariainfection.Theimportanceofheterologousprime-booststrategyinmalariainfectionhasbeendemonstratedbyanumberofstudies.Inthepresentstudy,primingwithP.vivaxMSP-142plasmidDNAandboostingwithrecombinantPvMSP-142proteinexhibitedasignificantincreaseintheantibodyresponsesinDNA/ProteingroupcomparedtoDNA/DNAgroupasitwasevidentoncomparingthe1ODtitreaswellasendpointtitrevaluesofdifferentimmunizedgroups.TheseresultssuggestthattheprimingwithplasmidDNAandboostingwithrecombinantproteinisessentialfortheenhancementofimmuneresponses.However,theantibodytitresinProtein/ProteingroupweresignificantlyhigherthanDNA/Proteingroup.ThismaybeattributedtotheuseofFCA/IFAforproteinimmunizationwhichresultedinhighlevelsofantibodyinProtein/Proteingroup.Previousstudieshaveshownthatcellmediatedimmuneresponses,inadditiontoantibodyresponses,arerequiredforprotectionagainstmalaria.PresentstudyonmeasuringTcellresponsesinmiceafterDNAimmunizationandproteinboostingexhibitedthatTcellproliferationwassignificantlyenhancedinDNA/ProteinandProtein/Proteingroups.Elevatedlevelsofcytokines(IL-2,IL-12,andIFN-γ)andhightitresofantigenspecificIgGisotypes(IgG1>IgG2b>IgG2a)indicatedthatbothTh1andTh2subsetsofThelpercellsmaybeproducedduringimmunizationofmiceinthepresentstudy.Thistypeofresponses,i.e.,theactivationofbothTh1andTh2cells,isconsideredidealforablood-stagevaccine.OurfindingsonDNAprimeandproteinboostinghavealsoindicatedthatamongtheDNAimmunizedgroups,primingwithDNAandboostingwithproteinclearlyelevatedthelevelsofallthecytokinesinDNA/ProteingroupsuggestingthatDNAcanprimethemicebutitselfisnotsufficientenoughtoenhancetheimmuneresponses.5.ConclusionsInthepresentstudy,wehavecloned42kDafragmentofP.vivaxmerozoitesurfaceprotein-1(PvMSP-142)ineukaryoticexpressionvectorpcDNA3.1.WecheckedtheinvitroexpressionofPvMSP-142-pcDNA3.1inCOS-1cellline.Indirectfluorescentassayandwesternblottingconfirmed
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年中國開槽機(jī)行業(yè)市場深度研究及發(fā)展趨勢預(yù)測報(bào)告
- 2025年度能源項(xiàng)目資料承包合同
- 2誰的植物長得好 教學(xué)設(shè)計(jì)-2024-2025學(xué)年科學(xué)二年級(jí)上冊(cè)人教鄂教版
- 2025年金屬器具合作協(xié)議書
- 2025年度體育場館地坪鋪設(shè)及運(yùn)動(dòng)性能提升分包協(xié)議
- 專題17 語言文字運(yùn)用(標(biāo)點(diǎn)類)- 2025年高考復(fù)習(xí)近十年之語文真題分項(xiàng)匯編 (解析卷)
- 03 2 首屆諾貝爾獎(jiǎng)?lì)C發(fā)2024-2025學(xué)年八年級(jí)語文上冊(cè)同步教學(xué)設(shè)計(jì)(河北專版)
- 2025年寵物臨時(shí)寄養(yǎng)服務(wù)合同范本
- 7聽聽秋的聲音 教學(xué)設(shè)計(jì)-2024-2025學(xué)年語文三年級(jí)上冊(cè)統(tǒng)編版
- 2025年度金融信息服務(wù)保密競業(yè)限制及知識(shí)產(chǎn)權(quán)歸屬共享協(xié)議
- 2024年北京電子科技職業(yè)學(xué)院高職單招語文歷年參考題庫含答案解析
- 2024版消防設(shè)計(jì)質(zhì)量問題案例分析手冊(cè)建筑機(jī)電專業(yè)
- 《業(yè)財(cái)一體化實(shí)訓(xùn)教程-金蝶云星空V7.5》
- 人教版二年級(jí)數(shù)學(xué)下冊(cè)第一單元綜合測評(píng)卷(含答案)
- 社區(qū)意識(shí)形態(tài)工作2025年度工作計(jì)劃
- 2025年山東省濟(jì)南廣播電視臺(tái)招聘30人歷年管理單位筆試遴選500模擬題附帶答案詳解
- DG-TJ 08-2048-2024 民用建筑電氣防火設(shè)計(jì)標(biāo)準(zhǔn)
- 2025年中智集團(tuán)招聘筆試參考題庫含答案解析
- 黑龍江省哈爾濱市南崗區(qū)2024-2025學(xué)年九年級(jí)上學(xué)期期末考試英語試題(含答案)
- 殘疾人就業(yè)培訓(xùn)
- Photoshop+2024學(xué)習(xí)手冊(cè):第1課認(rèn)識(shí)與操作基礎(chǔ)
評(píng)論
0/150
提交評(píng)論